Exact Sciences
EXAS
#1148
Rank
C$28.25 B
Marketcap
C$148.03
Share price
0.00%
Change (1 day)
96.04%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Operating Margin for Exact Sciences (EXAS)

Operating Margin as of November 2026 (TTM): -6.27%

According to Exact Sciences's latest financial reports and stock price the company's current Operating Margin is -6.27%. At the end of 2022 the company had an Operating Margin of -30.35%.

Operating Margin history for Exact Sciences from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-30.35%-36.34%
2021-47.68%-17.04%
2020-57.47%87.32%
2019-30.68%-20.35%
2018-38.52%-10.58%
2017-43.08%-74.4%
2016-168.26%-57.95%
2015-400.14%-92.81%
2014-5,564.40%395.74%
2013-1,122.44%-11.27%
2012-1,264.99%82.71%
2011-692.36%212.87%
2010-221.29%14.31%
2009-193.59%-82.09%
2008-1,080.85%171.83%
2007-397.61%39.94%
2006-284.13%-19.54%
2005-353.13%-9.21%
2004-388.96%-60.87%
2003-994.07%-70.16%
2002-3,331.44%-93.52%
2001-51,406.44%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Sanofi
SNY
13.21%-310.69%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
20.64%-429.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
31.38%-600.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-47.91% 664.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-124.57% 1,886.76%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.